The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
122161503 12216150 3 F 20160624 20160329 20160708 EXP GB-AUROBINDO-AUR-APL-2016-03703 AUROBINDO 22.00 YR F Y 0.00000 20160708 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
122161503 12216150 1 PS Lamotrigine Tablet LAMOTRIGINE 1 Unknown 100 MG, UNK, 150 MILLIGRAM DAILY; ONE 100MG TABLET AND HALF 100 MG TABLET Y U 78956 TABLET
122161503 12216150 2 SS Lamotrigine Tablet LAMOTRIGINE 1 Oral 200 MG, UNK ,200 MILLIGRAM DAILY; UNK Y U 78956 TABLET
122161503 12216150 3 SS LAMICTAL LAMOTRIGINE 1 Oral 50 MG, UNK U U 0 50 MG TABLET
122161503 12216150 4 SS LAMICTAL LAMOTRIGINE 1 Oral 100 MG, UNK U U 0 100 MG TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
122161503 12216150 1 Seizure
122161503 12216150 3 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
122161503 12216150 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
122161503 12216150 Asthma
122161503 12216150 Dementia
122161503 12216150 Headache
122161503 12216150 Hypersensitivity
122161503 12216150 Infection
122161503 12216150 Nasal congestion
122161503 12216150 Seizure
122161503 12216150 Swelling face

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found